Series A
$81m
Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement
Biotech startup Entact Bio has launched with an $81 million Series A funding its Encompass platform, which designs molecules that enhance protein function, backed by Qiming Venture Partners USA, venBio Partners and others.